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Summary Prognosis of adenocarcinoma of the pancreas has remained poor, but a few patients are reported
to live 5 years or longer after the diagnosis. Using the data of the Finnish Cancer Registry, we could identify
only 78 patients (1.3%) who had survived for longer than 5 years after the diagnosis of pancreatic cancer
among 5,837 patients diagnosed in Finland in 1975-1984. However, in 33 of the 78 cases a histological
diagnosis of pancreatic cancer had never been made, and the majority of the remaining 45 patients turned out
not to have pancreatic adenocarcinoma after a review. The results suggest that the majority of patients with
long-term survival following the diagnosis of pancreatic cancer have never had pancreatic adenocarcinoma.
Taking a biopsy from a suspected pancreatic neoplasm and careful histological evaluation may prohibit
misdiagnosis of this highly lethal disease.
Up to 97% of pancreatic cancers are ductal adenocarcinomas
(Morohoshi et al., 1983; Kloppel, 1984). Prognosis of pan-
creatic adenocarcinoma is poor, about 90% of patients will
die within 1 year from the diagnosis (Gudjonsson, 1987).
Longer survival times have been reported only for certain
histological types of pancreatic cancer, such as neuroendo-
crine tumours and cystic variant of carcinoma (Forrest &
Longmire, 1979; Compagno & Oertel, 1978; Hodgkinson et
al., 1978; Mathieu et al., 1989).
Stage and grade are well-known prognostic factors in pan-
creatic cancer, and tumours that originate in the pancreatic
head are associated with better prognosis than those found in
the body or the tail (Kloppel & Maillet, 1989; Braganza &
Howat, 1972). Periampullary carcinomas, which in clinical
studies are sometimes combined with bile duct cancers, are
usually smaller and associated with a better prospects of cure
(Michelassi et al., 1989).
Radical surgery has been considered to be the only chance
for long-term survival in pancreatic cancer. Even the results
of extensive surgery have, however, been poor, although
some recent studies report a 5-year survival rate of about
30% (Carter, 1990; Doerr et al., 1990; Trede et al., 1990).
In the present study we examined the 5-year survivors
from pancreatic cancer diagnosed during the 10-year period
from 1975 to 1984 in Finland. The results show that long-
term survivors from pancreatic (extra-ampullary) adenocar-
cinoma were still almost non-existent in Finland despite the
advanced health care system.
Materials and methods
In 1975-1984 5,837 patients (2,499 males) with cancer of the
pancreas were recorded in the Finnish Cancer Registry,
which is population-based and nationwide. Hospitals, patho-
logical and hematological laboratories, and practicing physi-
cians are requested to report all cases of cancer that come to
their attention to the Registry. All death certificates in which
cancer is mentioned are obtained from the Central Statistical
Office of Finland. In addition, all living cancer patients in the
files of the Cancer Registry are annually checked against the
death register to obtain information of non-cancerous causes
of death. Of the 5,837 cancers, 677 (12%) were found at
autopsy. According to data from the Registry, 221 patients
had been subject to radical surgery (98 males, 123 females).
A total of 78 patients (1.5%; 41 males, 37 females) sur-
vived for 5 years or more after the diagnosis. These 78
patients form the basis of this study. Clinical data were
obtained for these 78 patients from the hospitals where the
diagnosis of pancreatic cancer had been made. Histological
specimens of the tumour were reviewed, and new sections
were cut for special stainings, when necessary. Immunostain-
ing for synaptophysin was used to confirm the origin of the
neuroendocrine tumours. In addition, staining for insulin,
gastrin, glucagon, pancreatic polypeptide, somatostatin, and
vasoactive intestinal polypeptide were used. Staining for
leucocyte common antigen was used to confirm the diagnosis
of lymphoma.
Results
A summary of the results is shown in Table I. In 33 cases
(42%) out of 78, the diagnosis of pancreatic cancer had been
based on macroscopical findings at laparotomy or on radio-
logical or clinical evidence only, without any histopatho-
logical or cytological confirmation on the nature of the
tumour. In addition, in one case no histopathological
material was available for review (original diagnosis was
adenocarcinoma grade I).
Six lesions were non-neoplastic; there was only inflamma-
tion and/or fibrosis in the slices available for reclassification.
Table I Histological findings among 78 patients who survived at least
for 5 years after the diagnosis of malignant pancreatic tumour
n (%)
No histological biopsy taken from pancreas
Histological material no longer available
Benign lesion
- Inflammation/fibrosis
- Pancreatic cystadenoma
Other than pancreatic cancer
- Prostatic adenocarcinoma
- Ovarian carcinoma
Cancer involving pancreatic, origin uncertain
- Concurrent breast carcinoma
- Breast carcinoma in history
- Large anaplastic carcinoma involving both the
pancreas and the liver
Carcinoid tumour
Cystic lesion of borderline malignancy
Neuroendocrine tumour of the pancreas
Pancreatic cancer
- Pancreatic angiosarcoma
- Lymphoma
- Ampullary or periampullary carcinoma
- Adenocarcinoma of the pancreatic head
6
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1 (1%)
8 (10%)
2 (3%)
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21 (27%)
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Four tumours were cystic, and of these two were considered
in accordance with the original diagnosis to be of borderline
malignancy, and two were benign cystadenomas.
In two cases (3%) the origin of carcinoma could not be
established to be in the pancreas. One patient had adenocar-
cinoma of the prostate and another ovarian carcinoma. In
three cases (4%) cancer involved the pancreas but its origin
was uncertain: one patient had concurrent breast cancer,
another had a history of breast cancer, and the third had a
large poorly differentiated abdominal tumour involving both
the pancreas and the liver with the original diagnosis of
either hepatoma or pancreatic cancer. Among the remaining
cases there were one carcinoid tumour and seven pancreatic
neuroendocrine tumours.
Seventeen tumours were ampullary or periampullary
cancers. In 14 of these carcinomas the size of the tumour
could be determined, and the median size was found to be
2.1 cm (range, from 0.8 to 5 cm). One angiosarcoma and two
lymphomas were found among the remaining cases. Only one
case turned out to be an adenocarcinoma located clearly
outside the ampullary region.
The original histological diagnosis was changed in five of
the 78 cases as a result of the review. Two of the five
tumours were pancreatic neuroendocrine tumours, one lym-
phoma, one prostatic carcinoma and in one case no car-
cinoma could be found in the histological material available.
In four other cases the cytological or frozen section diagnosis
had been pancreatic carcinoma and the final diagnosis was
benign, but the final diagnosis had failed to reach the Cancer
Registry.
The patient with confirmed pancreatic adenocarcinoma
was a 66-year-old man, who was subjected to pancreatico-
duodenectomy and was found to have a 1 x 2 cm tumour in
the pancreatic head. The tumour was well-differentiated
adenocarcinoma with perineural infiltration. A small lymph
node metastasis was also discovered in histological examina-
tion.
Seventeen of the 45 patients with a histologically inves-
tigated tumour had surgery considered as radical.
Discussion
Long-term survival from pancreatic cancer is rare (Gudjons-
son, 1987). A large proportion of the long-term survivors had
a histologically undiagnosed tumour. It is likely that the
majority of these tumours were not pancreatic cancers at all.
Furthermore, some of the remaining long-term survivors had
a histologically misdiagnosed tumour, or the final diagnosis
had never been reported to the Cancer Registry making the
true long-term survival from pancreatic cancer exceedingly
rare.
The distinction between periampullary and other pan-
creatic adenocarcinoma is not always easy. However, this
distinction should, at least from the clinical point of view, be
done, because surgery leads more often to cure in periampul-
lary cancers which are typically small in size. In a recent
series from Finland, patients with periampullary cancer
treated with pancreaticoduodenectomy or total pancreatec-
tomy had a 5-year survival rate of 40% as compared with
0% in patients with adenocarcinoma in some other part of
the pancreas (P<0.001) (Kairaluoma et al., 1989). Similar
results have been reported from elsewhere (Cubilla & Fitz-
gerald, 1980; Michelassi et al., 1989).
Misdiagnosis of pancreatic cancer may lead to unnecessary
treatment with undue physical suffering, and the impact of a
cancer diagnosis with poor prognosis is likely to be often
disastrous to psychological well-being. Furthermore, misdiag-
noses may also lead to erroneously good treatment results
being reported in the medical literature. For example, in the
current study according to the original data obtained from
the Finnish Cancer Registry the 5-year survival rate of
patients who had undergone radical surgery was as high as
11.6 and 14.7% for males and females, respectively.
We suggest that the diagnosis of pancreatic cancer should
not be based on the macroscopical appearance of the tumour
at laparotomy or on radiological findings alone even if the
diagnosis of cancer appears clinically evident, but a histo-
logical diagnosis should be pursued. Immunohistochemistry
and other confirmatory examinations should be considered
whenever the histological diagnosis of pancreatic adenocar-
cinoma remains uncertain, and the final diagnosis should be
made available to cancer registries. A distinction between
periampullary cancer and pancreatic adenocarcinomas
appears to be important, and clear guidelines for reporting
and classification of these tumours separately should be
created. This means, among other things, that the ICD
(International Classification of Diseases) should include
cancer of the periampullary part of the pancreas as a sub-
category of pancreatic cancer. The recently accepted version
(ICD-10) does not recognise this subcategory.
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